These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27507060)

  • 1. Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors.
    Lobos-González L; Silva V; Araya M; Restovic F; Echenique J; Oliveira-Cruz L; Fitzpatrick C; Briones M; Villegas J; Villota C; Vidaurre S; Borgna V; Socias M; Valenzuela S; Lopez C; Socias T; Varas M; Díaz J; Burzio LO; Burzio VA
    Oncotarget; 2016 Sep; 7(36):58331-58350. PubMed ID: 27507060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo knockdown of antisense non-coding mitochondrial RNAs by a lentiviral-encoded shRNA inhibits melanoma tumor growth and lung colonization.
    Varas-Godoy M; Lladser A; Farfan N; Villota C; Villegas J; Tapia JC; Burzio LO; Burzio VA; Valenzuela PDT
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):64-72. PubMed ID: 28707763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial ASncmtRNA-1 and ASncmtRNA-2 as potent targets to inhibit tumor growth and metastasis in the RenCa murine renal adenocarcinoma model.
    Borgna V; Villegas J; Burzio VA; Belmar S; Araya M; Jeldes E; Lobos-González L; Silva V; Villota C; Oliveira-Cruz L; Lopez C; Socias T; Castillo O; Burzio LO
    Oncotarget; 2017 Jul; 8(27):43692-43708. PubMed ID: 28620146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy.
    Vidaurre S; Fitzpatrick C; Burzio VA; Briones M; Villota C; Villegas J; Echenique J; Oliveira-Cruz L; Araya M; Borgna V; Socías T; Lopez C; Avila R; Burzio LO
    J Biol Chem; 2014 Sep; 289(39):27182-27198. PubMed ID: 25100722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors.
    Borgna V; Lobos-González L; Guevara F; Landerer E; Bendek M; Ávila R; Silva V; Villota C; Araya M; Rivas A; López C; Socias T; Castillo J; Alarcón L; Burzio LO; Burzio VA; Villegas J
    J Cancer; 2020; 11(7):1780-1791. PubMed ID: 32194789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol analogue, trans-4,4'-dihydroxystilbene (DHS), inhibits melanoma tumor growth and suppresses its metastatic colonization in lungs.
    Saha B; Pai GB; Subramanian M; Gupta P; Tyagi M; Patro BS; Chattopadhyay S
    Biomed Pharmacother; 2018 Nov; 107():1104-1114. PubMed ID: 30257322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors.
    Fitzpatrick C; Bendek MF; Briones M; Farfán N; Silva VA; Nardocci G; Montecino M; Boland A; Deleuze JF; Villegas J; Villota C; Silva V; Lobos-Gonzalez L; Borgna V; Barrey E; Burzio LO; Burzio VA
    Cell Death Dis; 2019 May; 10(6):423. PubMed ID: 31142736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
    Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
    BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
    Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
    J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth.
    Liu Y; Zhang Y; Zheng X; Zhang X; Wang H; Li Q; Yuan K; Zhou N; Yu Y; Song N; Fu J; Min W
    Oncotarget; 2016 May; 7(22):32329-40. PubMed ID: 27058624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient in vivo microRNA targeting of liver metastasis.
    Huynh C; Segura MF; Gaziel-Sovran A; Menendez S; Darvishian F; Chiriboga L; Levin B; Meruelo D; Osman I; Zavadil J; Marcusson EG; Hernando E
    Oncogene; 2011 Mar; 30(12):1481-8. PubMed ID: 21102518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis.
    Contador-Troca M; Alvarez-Barrientos A; Barrasa E; Rico-Leo EM; Catalina-Fernández I; Menacho-Márquez M; Bustelo XR; García-Borrón JC; Gómez-Durán A; Sáenz-Santamaría J; Fernández-Salguero PM
    Carcinogenesis; 2013 Dec; 34(12):2683-93. PubMed ID: 23843039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo knockdown of CXCR4 using jetPEI/CXCR4 shRNA nanoparticles inhibits the pulmonary metastatic potential of B16‑F10 melanoma cells.
    André ND; Silva VA; Ariza CB; Watanabe MA; De Lucca FL
    Mol Med Rep; 2015 Dec; 12(6):8320-6. PubMed ID: 26498029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation.
    Bahrambeigi V; Ahmadi N; Salehi R; Javanmard SH
    Immunol Invest; 2015; 44(3):216-36. PubMed ID: 25565576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
    Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
    Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroid differentiation regulator 1, an interleukin 18-regulated gene, acts as a metastasis suppressor in melanoma.
    Jung MK; Park Y; Song SB; Cheon SY; Park S; Houh Y; Ha S; Kim HJ; Park JM; Kim TS; Lee WJ; Cho BJ; Bang SI; Park H; Cho D
    J Invest Dermatol; 2011 Oct; 131(10):2096-104. PubMed ID: 21697887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
    Tai KF; Wang CH
    Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
    Feichtenschlager V; Chen L; Zheng YJ; Ho W; Sanlorenzo M; Vujic I; Fewings E; Lee A; Chen C; Callanan C; Lin K; Qu T; Hohlova D; Vujic M; Hwang Y; Lai K; Chen S; Nguyen T; Muñoz DP; Kohwi Y; Posch C; Daud A; Rappersberger K; Kohwi-Shigematsu T; Coppé JP; Ortiz-Urda S
    Mol Cancer; 2024 Feb; 23(1):40. PubMed ID: 38383439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice.
    Sun Y; Lin R; Dai J; Jin D; Wang SQ
    Oligonucleotides; 2006; 16(4):365-74. PubMed ID: 17155911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.